The relationship of oral chlorpyrifos effects on behavior, cholinesterase inhibition, and muscarinic receptor density in rat

Pharmacology Biochemistry and Behavior

Volumn 58, Issue 1, 1997, Pages 15-23

  Nostrandt, Amy C ^a   Padilla, Stephanie ^b   Moser, Virginia C ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Chlorpyrifos; Cholinesterase inhibition; Functional observational battery; Muscarinic receptors; Neurobehavior; Rat

Indexed keywords

CHLORPYRIFOS; INSECTICIDE; MUSCARINIC RECEPTOR; QUINUCLIDINYL BENZILATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN; CHOLINESTERASE INHIBITION; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; MALE; MEDULLA OBLONGATA; MOTOR ACTIVITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION;

ANIMALS; AUTONOMIC NERVOUS SYSTEM; BEHAVIOR, ANIMAL; BRAIN; CHLORPYRIFOS; CHOLINESTERASE INHIBITORS; CHOLINESTERASES; DOSE-RESPONSE RELATIONSHIP, DRUG; GAIT; INSECTICIDES; MALE; MOTOR ACTIVITY; RATS; RECEPTORS, MUSCARINIC; TISSUE DISTRIBUTION;

ANIMALIA; CETACEA;

EID: 0030754875     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00458-3     Document Type: Article

References (41)

1. Annau Z. A. Effects of organophosphorus compounds. Chambers J. E., Levi P. E. Organophosphates. chemistry fate and effects:1992;419-432 Academic Press, San Diego, CA.
2. Bignami G., Rosic N., Michalek H., Milosevic M., Gatti G. L. Behavioral toxicity of anticholinesterase agents. Methodological, neurochemical, and neuropsychological aspects Weiss B., Laties V. G. Behavioral toxicology. 1975;155-216 Plenum Press, New York.
3. Carr R. L., Chambers J. E. Acute effects of the organophosphate paraoxon on schedule-controlled behavior and esterase activity in rats. Dose-response relationships Pharmacol. Biochem. Behav. 40:1991;929-936.
4. Chaudhuri J., Chakraborti T. K., Chanda S., Pope C. N. Differential modulation of organophosphate-sensitive muscarinic receptors in rat brain by parathion and chlorpyrifos. J. Biochem. Toxicol. 8:1993;207-216.
5. Cochran R. C., Kishiyama J., Aldous C., Carr W. C. Jr., Pfeifer K. F. Chlorpyrifos. Hazard assessment based on a review of the effects of short-term and long-term exposure in animals and humans Food Chem. Toxicol. 33:1995;165-172.
6. Costa L. G. Role of second-messenger systems in response to organophosphorus compounds. Chambers J. E., Levi P. E. Organophosphates. chemistry, fate and effects:1992;271-432 Academic Press, San Diego, CA.
7. Creason J. P. Data evaluation and statistical analysis of functional observational battery data using a linear models approach. J. Am. Coll. Toxicol. 8:1989;157-169.
8. D'Mello G. D. Neurobehavioral toxicology of anticholinesterases. Ballantyne B., Marrs T. C. Clinical and experimental toxicology of organophosphates and carbamates. 1992;61-74 Butterworth-Heinemann Ltd, Oxford, UK.
9. D'Mello G. D. Behavioral toxicity of anticholinesterases in humans and animals - A review. Hum. Exp. Toxicol. 12:1993;3-7.
10. Dutta H., Marcelino J., Richmonds C. Brain acetylcholinesterase activity and optomotor behavior in bluegills, Lepomis macrochirus exposed to different concentrations of diazinon. Arch. Int. Physiol. Biochim. Biophys. 100:1992;331-334.
11. Ecobichon D. J. Pesticides. Amdur M. O., Doull J., Klaasen C. D. Casarett and Doull's toxicology. the basic science of poisons 4:1991;580-592 Pergamon Press, New York.
12. Ehrich M., Shell L., Rozum M., Jortner B. S. Short-term clinical and neuropathologic effects of cholinesterase inhibitors in rats. J. Am. Coll. Toxicol. 12:1993;55-68.
13. Ellman G. L., Courtney K. D., Andres V. Jr., Featherstone R. M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7:1961;88-95.
14. Goldberg M. E., Johnson H. E., Knaak J. B. Inhibition of discrete avoidance behavior by three anticholinesterase agents. Psychopharmacologia. 7:1965;72-76.
15. Hart A. D. M. Relationships between behavior and the inhibition of acetylcholinesterase in birds exposed to organophosphorus pesticides. Environ. Toxicol. Chem. 12:1993;321-336.
16. Hoskins B., Fernando J. C. R., Dulaney M. D., Lim D. K., Liu D. D., Watanabe H. K., Ho I. K. Relationship between the neurotoxicities of soman, sarin and tabun, and acetylcholinesterase inhibition. Toxicol. Lett. 30:1986;121-129.
17. Johnson C. D., Russell R. L. A rapid, simple radiometric assay for cholinesterase, suitable for multiple determinations. Anal. Biochem. 64:1975;229-238.
18. Kurtz P. J. Behavioral and biochemical effects of the carbamate insecticide, mobam. Pharmacol. Biochem. Behav. 6:1977;303-310.
19. Kurtz P. J. Dissociated behavioral and cholinesterase decrements following malathion exposure. Toxicol. Appl. Pharmacol. 42:1977;589-594.
20. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
21. Lynch M. R., Rice M. A., Robinson S. E. Dissociation of locomotor depression and ChE activity after DFP, soman, and sarin. Pharmacol. Biochem. Behav. 24:1986;941-947.
22. Marrs T. C. Organophosphate poisoning. Pharmacol. Ther. 5:1993;51-66.
23. McDaniel K. L., Moser V. C. Utility of a neurobehavioral screening battery for differentiating the effects of two pyrethroids, permethrin and cypermethrin. Neurotoxicol. Teratol. 15:1993;71-83.
24. Moser V. C. Comparisons of the acute effects of cholinesterase inhibitors using a neurobehavioral screening battery in rats. Neurotoxicol. Teratol. 17:1995;617-625.
25. Moser V. C., McCormick J. P., Creason J. P., MacPhail R. C. Comparison of chlordimeform and carbaryl using a functional observational battery. Fundam. Appl. Toxicol. 11:1988;189-206.
26. Moss D. E., Rodriguez L. A., McMaster S. B. Comparative behavioral effects of CNS cholinesterase inhibitors. Pharmacol. Biochem. Behav. 22:1985;479-482.
27. Nostrandt A. C., Duncan J. A., Padilla S. A modified spectrophotometric method appropriate for measuring cholinesterase activity in tissue from carbaryl-treated animals. Fundam. Appl. Toxicol. 21:1993;196-203.
28. Padilla S. Regulatory and research issues related to cholinesterase inhibition. Toxicology. 102:1995;215-220.
29. Padilla S., Moser V. C., Pope C. N., Brimijoin W. S. Paraoxon toxicity is not potentiated by prior reduction in blood acetylcholinesterase. Toxicol. Appl. Pharmacol. 117:1992;110-115.
30. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 2:1986;Academic Press, San Diego, CA.
31. Pope C. N., Chakraborti T. K., Chapman M. L., Farrar J. D. Long-term neurochemical and behavioral effects induced by acute chlorpyrifos treatment. Pharmacol. Biochem. Behav. 42:1992;251-256.
32. Reiter L. W. Acute and subacute parathion treatment. Effects on cholinesterase activities and learning in mice Toxicol. Appl. Pharmacol. 25:1973;582-588.
33. Reiter L. W. Chemical exposures and animal activity. Utility of the figure-eight maze Hayes A. W., Schnell R. C., Miya T. S. Developments in the science and practice of toxicology. 1983;73-84 Elsevier, New York.
34. Roney P. L. Jr., Costa L. G., Murphy S. D. Conditioned taste aversion induced by organophosphate compounds in rats. Pharmacol. Biochem. Behav. 24:1986;737-742.
35. Ruppert P. H., Cook L. L., Dean K. F., Reiter L. W. Acute behavioral toxicity of carbaryl and propoxur in adult rats. Pharmacol. Biochem. Behav. 18:1983;579-584.
36. Russell R. W. Neurophysiological and biochemical correlates of effects of drugs on behaviour. The acetylcholine system Steinberg H., deReuck A. V. S., Knight J. Animal Behavior and Drug Action. 1964;144-159 London, Churchill.
37. SAS Institute Inc SAS/STAT user's guide, version 6. 1990;SAS Institute Inc, Cary, NC.
38. Volpe L. S., Biagnioni T. M., Marquis J. K. In vitro modulation of bovine caudate muscarinic receptor number by organophosphates and carbamates. Toxicol. Appl. Pharmacol. 78:1985;226-234.
39. Ward T. R., Ferris D. J., Tilson H. A., Mundy W. R. Correlation of the anticholinesterase activity of a series of organophosphates with their ability to compete with agonist binding to muscarinic receptors. Toxicol. Appl. Pharmacol. 122:1993;300-307.
40. Wecker L., Mobley P. L., Dettbarn W.-D. Central cholinergic mechanisms underlying adaptation to reduced cholinesterase activity. Biochem. Pharmacol. 26:1977;633-637.
41. Yamamura H. I., Snyder S. H. Muscarinic cholinergic binding in rat brain. Proc. Natl. Acad. Sci. USA. 71:1974;1725-1729.